IDO1 and cancer: The discovery that targeting IDO1 could subvert the protection from maternal immunity that a hemiallogeneic fetus requires for successful gestation (14) was followed by demonstrations that inhibiting IDO1 could relieve T cell-directed immunological suppression in cancer (15–17).